文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

减重手术后非激素相关癌症风险的荟萃分析

Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies.
PubMed 文献 · Br J Surg · 2022-01-01

该荟萃分析纳入15项回顾性观察研究、共18 583 477例患者,比较减重手术组与非手术组的非激素相关癌症发生率。

要点

  • 胃旁路术和袖状胃切除术与癌症风险降低相关,可调节胃束带术未见差异
  • 肝癌、结直肠癌、肾及泌尿系癌、食管癌和肺癌风险在手术组均降低

核心结论

  • 减重手术与约50%的非激素相关癌症风险降低相关

研究设计与样本

  • 检索Cochrane、Embase、PubMed、Scopus和Web of Science 1984至2018年文献,遵循PRISMA系统,采用随机效应模型荟萃分析,按手术方式和癌症类型进行亚组分析
  • 共纳入15项回顾性观察研究,总计18 583 477例患者,减重手术组947 787例,对照组17 635 690例

主要发现

  • Roux-en-Y胃旁路术和袖状胃切除术与癌症风险降低相关,可调节胃束带术未见差异
  • 肝癌OR 0.417(95%CI 0.323-0.538),结直肠癌OR 0.64(95%CI 0.49-0.84),肾及泌尿系癌OR 0.77(95%CI 0.72-0.83),食管癌OR 0.60(95%CI 0.43-0.85),肺癌OR 0.796(95%CI 0.45-0.80)

临床怎么用

  • 对肥胖患者行减重手术决策时,可将非激素相关癌症风险降低作为额外获益进行告知
  • 胃旁路术和袖状胃切除术在癌症风险降低方面可能优于可调节胃束带术

局限性

  • 纳入研究均为回顾性观察性研究,存在选择偏倚和混杂因素可能
  • 检索时间截至2018年,未纳入此后发表的研究

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity is associated with an increased incidence of at least 13 types of cancer. Although bariatric surgery has been associated with a reduced risk of hormonal cancers, data for non-hormonal cancers are scarce. The aim of this study was to evaluate the effect of bariatric surgery on the incidence of non-hormonal cancers. METHODS: Cochrane, Embase, PubMed, Scopus, and Web of Science were searched for articles between 1984 and 2018, following the PRISMA system. Meta-analysis was conducted using a random-effect model with subgroup analysis by procedure and cancer type. RESULTS: From 2526 studies screened, 15 were included. There were a total of 18 583 477 patients, 947 787 in the bariatric group and 17 635 690 in the control group. In comparison to the non-surgical group, the bariatric group had a lower incidence of cancer (OR .65 (95 per cent c.i. 0.53 to 0.80); P < 0.002). In the subgroup analysis, Roux-en-Y gastric bypass and sleeve gastrectomy were associated with decreased risk of developing cancer, while no difference was observed with adjustable gastric banding. When evaluated by cancer type, liver (OR 0.417 (95 per cent c.i. 0.323 to 0.538)), colorectal (OR 0.64 (95 per cent c.i. 0.49 to 0.84)), kidney and urinary tract cancer (OR 0.77 (95 per cent c.i. 0.72 to 0.83)), oesophageal (OR 0.60 (95 per cent c.i. 0.43 to 0.85)), and lung cancer (OR 0.796 (95 per cent c.i. 0.45 to 0.80)) also presented a lower cancer incidence in the bariatric group. CONCLUSION: Bariatric surgery is related to an almost 50 per cent reduction in the risk of non-hormonal cancers.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Clapp B, Portela R, Sharma I, et al. Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies. Br J Surg. 2022. PMID: 36259310. doi:10.1093/bjs/znac343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。